Search

everythinglearnresearchcommunity

for

Search:↓

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Hair loss may indicate higher heart risk and metabolic issues.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Biotin treatment can significantly improve hair loss and motor functions in certain metabolic disorders.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

A new gene mutation causes insulin resistance in a girl and her mother.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

A woman developed a severe skin reaction called toxic epidermal necrolysis after taking the antibiotic cephalexin.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Obese women with PCOS are more likely to have fatty liver disease.

Early balding men may have insulin resistance, but lifestyle changes can help.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Orlistat might block the body's ability to absorb thyroid medication.

Recognizing and treating early signs of insulin resistance can help prevent type 2 diabetes and improve life quality.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.